Hydroxyethyl starch (HES) products - increased risk of renal dysfunction and mortality

Sign up for your FREE ticket to see PharmData at the Pharmacy Show to see our latest products and features demonstrated live!

Hydroxyethyl starch (HES) products - increased risk of renal dysfunction and mortality

2014-12-17 15:00:57 (11 year(s) ago)

Summary

(B Braun Melsungen AG and Fresenius Kabi Limited) Increased risk of renal dysfunction and mortality in critically ill or septic patients– class 1 action within 48 hours. (EL (13)A/18)

Read full MHRA article

Respond to this alert